Evidence map›Paper›PMID 36104003›Full record

ArticleSleep2022

Biomarker associations with insomnia and secondary sleep outcomes in persons with and without HIV in the POPPY-Sleep substudy: a cohort study.

Nicholas Bakewell, Caroline A Sabin, Riya Negi, Alejandro Garcia-Leon, Alan Winston, Memory Sachikonye, Nicki Doyle, Susan Redline, Patrick W G Mallon, Ken M Kunisaki

Open access · hybridAbstract read
In one paragraph

Article in Sleep, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Nicholas BakewellInstitute for Global Health, University College London, London, UK.
Caroline A SabinInstitute for Global Health, University College London, London, UK.
Riya NegiCentre for Experimental Pathogen Host Research, School of Medicine, University College Dublin, Ireland.
Alejandro Garcia-LeonCentre for Experimental Pathogen Host Research, School of Medicine, University College Dublin, Ireland.
Alan WinstonDepartment of Infectious Disease, Imperial College London, London, UK.
Memory SachikonyeUK Community Advisory Board (UK-CAB), London, UK.
Nicki DoyleDepartment of Infectious Disease, Imperial College London, London, UK.
Susan RedlineBrigham and Women's Hospital, Boston, USA.ORCID 0000-0002-6585-1610
Patrick W G MallonCentre for Experimental Pathogen Host Research, School of Medicine, University College Dublin, Ireland.
Ken M KunisakiMinneapolis Veterans Affairs Health Care System, Minneapolis, USA.ORCID 0000-0001-8644-2827
University College Dublin · IEImperial College London · GBUniversity College London · GBBoston University · USUniversity of Minnesota · US

Funding

Sleep, Aging, and HIV Infection Cohort StudyR01HL131049 · NHLBI · UNIVERSITY OF MINNESOTA · PI KUNISAKI, KEN M., REDLINE, SUSAN S. · 2016 to 2019
$2.4M
NHLBI NIH HHS R01 HL131049
6 · The paper itself

Abstract

STUDY

objectivesWe investigated associations between inflammatory profiles/clusters and sleep measures in people living with HIV and demographically-/lifestyle-similar HIV-negative controls in the Pharmacokinetic and clinical Observations in PeoPle over fiftY (POPPY)-Sleep substudy.

methodsPrimary outcome was insomnia (Insomnia Severity Index [ISI]>15). Secondary sleep outcomes included 7-day actigraphy (e.g. mean/standard deviation of sleep duration/efficiency), overnight oximetry (e.g. oxygen desaturation index [ODI]) and patient-reported measures (Patient-Reported Outcomes Measurement Information System (PROMIS) sleep questionnaires). Participants were grouped using Principal Component Analysis of 31 biomarkers across several inflammatory pathways followed by cluster analysis. Between-cluster differences in baseline characteristics and sleep outcomes were assessed using Kruskal-Wallis/logistic regression/Chi-squared/Fisher's exact tests.

resultsOf the 465 participants included (74% people with HIV, median [interquartile range] age 54 [50-60] years), only 18% had insomnia and secondary sleep outcomes suggested generally good sleep (e.g. ODI 3.1/hr [1.5-6.4]). Three clusters with distinct inflammatory profiles were identified: "gut/immune activation" (n = 47), "neurovascular" (n = 209), and "reference" (relatively lower inflammation; n = 209). The "neurovascular" cluster included higher proportions of people with HIV, obesity (BMI>30 kg/m2), and previous cardiovascular disease, mental health disorder, and arthritis of knee/hip relative to the other two clusters. No clinically relevant between-cluster differences were observed in proportions with insomnia (17%, 18%, 20%) before (p = .76) or after (p = .75) adjustment for potential confounders. Few associations were observed among actigraphy, oximetry, and PROMIS measures.

conclusionsAlthough associations could exist with other sleep measures or biomarker types not assessed, our findings do not support a strong association between sleep and inflammation in people with HIV.

Indexed as

HIV InfectionsPapaverSleep Initiation and Maintenance DisordersCohort StudiesHumansMiddle AgedSleepbiomarkersHIVinflammationinsomniasleep problems

Identifiers

PMID36104003
PMCPMC9742892
OpenAlexW4295793959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.